Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.
Moxon
E R
ER
University Department of Paediatrics, John Radcliffe Hospital, Oxford, U.K.
Hood
D
D
Richards
J
J
D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology*; D006192:Haemophilus Infections / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control*; D018073:Haemophilus Vaccines / Q000276:immunology*; D006193:Haemophilus influenzae / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D008070:Lipopolysaccharides / Q000096:biosynthesis / Q000737:chemistry / Q000276:immunology*; D008589:Meningococcal Infections / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control*; D009345:Neisseria meningitidis / Q000276:immunology*
D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; D008070:Lipopolysaccharides